l 741626 has been researched along with 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide in 1 studies
| Studies (l 741626) | Trials (l 741626) | Recent Studies (post-2010) (l 741626) | Studies (3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide) | Trials (3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide) | Recent Studies (post-2010) (3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide) |
|---|---|---|---|---|---|
| 76 | 0 | 33 | 60 | 0 | 45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, MA; Lewis, MH; Maletz, S; Muehlmann, AM | 1 |
1 other study(ies) available for l 741626 and 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide
| Article | Year |
|---|---|
Pharmacological targeting of striatal indirect pathway neurons improves subthalamic nucleus dysfunction and reduces repetitive behaviors in C58 mice.
Topics: Adenosine; Animals; Autism Spectrum Disorder; Basal Ganglia; Behavior, Animal; Benzamides; Compulsive Behavior; Corpus Striatum; Disease Models, Animal; Indoles; Male; Mice; Mice, Inbred Strains; Neural Pathways; Neurons; Phenethylamines; Piperidines; Pyrazoles; Stereotyped Behavior; Subthalamic Nucleus | 2020 |